Biobanking Market by Product Type, Distribution Channel, End User 2023-2028

1
Global Biobanking Market Research and Forecast
Report 2023-2028

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Biobanking Market Global Industry
  Trends, Share, Size, Growth, Opportunity and
  Forecast 2023-2028," the global biobanking market
  size reached US 57.5 Billion in 2022.
• Biobanking refers to the procedure of collecting
  and preserving human biospecimens that can be
  further used for diagnosis, biodiversity studies,
  and research. These specimens are stored for
  several years and are used by multiple
  researchers for cross-purpose research studies
  and to improve the understanding of health and
  different diseases.
• Over the years, biobanking has become a vital
  resource in medical research, supporting various
  types of contemporary research like genomics and
  personalized medicine.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/biobanking-market/reque
  stsample

4
Report Description

• Global Biobanking Market Trends
• The market is primarily driven by the growing
  prevalence of infectious and chronic diseases as
  biobanking is extensively used to develop
  diagnostics that can accurately and quickly
  identify pathogens. In addition, the escalating
  demand for regenerative medicine and personalized
  treatment represents another major
  growth-inducing factor. Besides this, health
  agencies of numerous countries are investing in
  virtual biobank network models that help
  investigators locate biospecimens and data mining
  from multiple biobanks. This, coupled with the
  significant developments in genomics, disease
  biology, metagenomics, proteomics, bioenergy, and
  environmental remediation, are positively
  influencing the market growth.
• Moreover, key players are integrating various
  advanced technologies with biobanking that
  assists healthcare professionals in collecting
  high-quality and well-annotated human
  biospecimens, and understanding pathogenic
  mechanisms. These advanced methods are also being
  utilized to identify therapeutic targets of
  coronavirus disease (COVID-19), which is also
  creating a positive market outlook across the
  globe.
• Looking forward, IMARC Group expects the market
  to reach US 82.3 Billion by 2028, expanding at a
  CAGR of 5.86 during the forecast period
  (2023-2028).
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/biobanking-market

5
Report Segmentation

• Specimen Type Insights
• Blood Products
• Solid Tissue
• Cell Lines
• Nucleic Acid
• Others
• Biobank Type Insights
• Population-based Biobanks
• Disease-oriented Biobanks
• Application Insights
• Therapeutics
• Research

6
Report Segmentation

• End-User Insights
• Academic Institutions
• Pharma and Biotech Companies
• Regional Insights
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• Brooks Automation Inc.
• Bay Biosciences LLC
• Boca Biolistics
• Ctibiotech
• Cureline Inc.
• Firalis
• Greiner Bio-One International GmbH
• Hamilton Company
• Merck KGaA
• ProteoGenex Inc.
• Thermo Fisher Scientific Inc.
• VWR Corporation (Avantor Inc.)

8
Key Questions Answered in the Report
9
Key Questions Answered in the Report
10
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Biobanking Market   
  5.1    Market Overview    5.2    Market
  Performance    5.3    Impact of COVID-19  5.4
     Market Forecast
• 6     Market Breakup by Specimen Type
• 6.1 Blood Products
• 6.1.1 Market Trends
• 6.1.2 Market Forecast
• 6.2 Solid Tissue
• 6.2.1 Market Trends
• 6.2.2 Market Forecast
• 6.3 Cell Lines
• 6.3.1 Market Trends
• 6.3.2 Market Forecast       

11
Table of Contents

• 6.4 Nucleic Acid
• 6.4.1 Market Trends
• 6.4.2 Market Forecast
• 6.5 Others
• 6.5.1 Market Trends
• 6.5.2 Market Forecast
• 7 Market Breakup by Biobank Type
• 7.1 Population-based Biobanks
• 7.1.1 Market Trends
• 7.1.2 Market Forecast
• 7.2 Disease-oriented Biobanks
• 7.2.1 Market Trends
• 7.2.2 Market Forecast
• 8 Market Breakup by Application
• 8.1 Therapeutics
• 8.1.1 Market Trends
• 8.1.2 Market Forecast
• 8.2 Research
• 8.2.1 Market Trends

12
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

13
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com